Duavee
(HVWDNZKFQJRWLR-NRTGCNNXSA-N)
Structure
- SMILES
- O=C1CC[C@@H]2[C@]1(C)CCc1c2ccc2c1ccc(c2)OS(=O)(=O)O.O=C1CC[C@@H]2[C@]1(C)CC[C@H]1C2=CCc2c1ccc(c2)OS(=O)(=O)O.O=C1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)OS(=O)(=O)O.Oc1ccc2c(c1)c(C)c(n2Cc1ccc(cc1)OCCN1CCCCCC1)c1ccc(cc1)O
- Molecular Formula:
- C84H94N2O18S3
- Molecular Weight:
- 1515.840
- Log P:
- 19.4386
- Hydrogen Bond Acceptor:
- 20
- Hydrogen Bond Donor:
- 5
- TPSA:
- 325.01
- CAS Number(s):
- N/A
Synonym(s)
1.
Duavee
External Link(s)
| PubChem Compound | 85364158 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 89 | US FAERS | |
| 2 | Nausea | FAERS: 20 | US FAERS | |
| 3 | Drug effect incomplete | FAERS: 17 | US FAERS | |
| 4 | Dizziness | FAERS: 14 | US FAERS | |
| 5 | Feeling abnormal | FAERS: 12 | US FAERS | |
| 6 | Headache | FAERS: 12 | US FAERS | |
| 7 | Neck Pain | FAERS: 12 | US FAERS | |
| 8 | Product use issue | FAERS: 12 | US FAERS | |
| 9 | Anxiety | FAERS: 10 | US FAERS | |
| 10 | Abdominal discomfort | FAERS: 9 | US FAERS | |
| 11 | Myalgia | FAERS: 9 | US FAERS | |
| 12 | Crying | FAERS: 8 | US FAERS | |
| 13 | Metrorrhagia | FAERS: 7 | US FAERS | |
| 14 | Pain | FAERS: 7 | US FAERS | |
| 15 | Pruritus | FAERS: 7 | US FAERS | |
| 16 | Vulvovaginal dryness | FAERS: 7 | US FAERS | |
| 17 | Arthralgia | FAERS: 6 | US FAERS | |
| 18 | Breast tenderness | FAERS: 6 | US FAERS | |
| 19 | Intentional product misuse | FAERS: 6 | US FAERS | |
| 20 | Malaise | FAERS: 6 | US FAERS | |
| 21 | Abdominal Pain | FAERS: 5 | US FAERS | |
| 22 | Back Pain | FAERS: 5 | US FAERS | |
| 23 | Deep Vein Thrombosis | FAERS: 5 | US FAERS | |
| 24 | Endometrial Hyperplasia | FAERS: 5 | US FAERS | |
| 25 | Fatigue | FAERS: 5 | US FAERS | |
| 26 | Night sweats | FAERS: 5 | US FAERS | |
| 27 | Premenstrual syndrome | FAERS: 5 | US FAERS | |
| 28 | Uterine Polyp | FAERS: 5 | US FAERS | |
| 29 | Vomiting | FAERS: 5 | US FAERS | |
| 30 | Bone pain | FAERS: 4 | US FAERS | |
| 31 | Drug dose omission | FAERS: 4 | US FAERS | |
| 32 | Dyspepsia | FAERS: 4 | US FAERS | |
| 33 | Joint swelling | FAERS: 4 | US FAERS | |
| 34 | Palpitations | FAERS: 4 | US FAERS | |
| 35 | Thrombosis | FAERS: 4 | US FAERS | |
| 36 | Acne | FAERS: 3 | US FAERS | |
| 37 | Amnesia | FAERS: 3 | US FAERS | |
| 38 | Bone density increased | FAERS: 3 | US FAERS | |
| 39 | Dry skin | FAERS: 3 | US FAERS | |
| 40 | Endometrial thickening | FAERS: 3 | US FAERS | |
| 41 | Menorrhagia | FAERS: 3 | US FAERS | |
| 42 | Mood swings | FAERS: 3 | US FAERS | |
| 43 | Oropharyngeal pain | FAERS: 3 | US FAERS | |
| 44 | Peripheral swelling | FAERS: 3 | US FAERS | |
| 45 | Pre-existing condition improved | FAERS: 3 | US FAERS | |
| 46 | Therapeutic response unexpected | FAERS: 3 | US FAERS | |
| 47 | Urticaria | FAERS: 3 | US FAERS | |
| 48 | Alopecia | FAERS: 2 | US FAERS | |
| 49 | Atrophic vulvovaginitis | FAERS: 2 | US FAERS | |
| 50 | Blood cholesterol increased | FAERS: 2 | US FAERS | |
| 51 | Burning sensation | FAERS: 2 | US FAERS | |
| 52 | Constipation | FAERS: 2 | US FAERS | |
| 53 | Depressed mood | FAERS: 2 | US FAERS | |
| 54 | Drug administration error | FAERS: 2 | US FAERS | |
| 55 | Drug ineffective for unapproved indication | FAERS: 2 | US FAERS | |
| 56 | Dysgeusia | FAERS: 2 | US FAERS | |
| 57 | Emotional disorder | FAERS: 2 | US FAERS | |
| 58 | Feeling of body temperature change | FAERS: 2 | US FAERS | |
| 59 | Limb discomfort | FAERS: 2 | US FAERS | |
| 60 | Malabsorption | FAERS: 2 | US FAERS | |
| 61 | Memory impairment | FAERS: 2 | US FAERS | |
| 62 | Musculoskeletal stiffness | FAERS: 2 | US FAERS | |
| 63 | Myocardial Infarction | FAERS: 2 | US FAERS | |
| 64 | Product storage error | FAERS: 2 | US FAERS | |
| 65 | Somnolence | FAERS: 2 | US FAERS | |
| 66 | Agitation | FAERS: 1 | US FAERS | |
| 67 | Anger | FAERS: 1 | US FAERS | |
| 68 | Anorgasmia | FAERS: 1 | US FAERS | |
| 69 | Arthropathy | FAERS: 1 | US FAERS | |
| 70 | Blood heavy metal increased | FAERS: 1 | US FAERS | |
| 71 | Blood thyroid stimulating hormone increased | FAERS: 1 | US FAERS | |
| 72 | Blood triglycerides increased | FAERS: 1 | US FAERS | |
| 73 | Bone density abnormal | FAERS: 1 | US FAERS | |
| 74 | Bone resorption test abnormal | FAERS: 1 | US FAERS | |
| 75 | Breast Cyst | FAERS: 1 | US FAERS | |
| 76 | Breast engorgement | FAERS: 1 | US FAERS | |
| 77 | Cataract | FAERS: 1 | US FAERS | |
| 78 | Contraindicated drug administered | FAERS: 1 | US FAERS | |
| 79 | Contraindicated product administered | FAERS: 1 | US FAERS | |
| 80 | Cyst | FAERS: 1 | US FAERS | |
| 81 | Discomfort | FAERS: 1 | US FAERS | |
| 82 | Disease Progression | FAERS: 1 | US FAERS | |
| 83 | Disease recurrence | FAERS: 1 | US FAERS | |
| 84 | Drug Tolerance | FAERS: 1 | US FAERS | |
| 85 | Drug effect delayed | FAERS: 1 | US FAERS | |
| 86 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 87 | Dyspareunia | FAERS: 1 | US FAERS | |
| 88 | Endometrial adenocarcinoma | FAERS: 1 | US FAERS | |
| 89 | Endometrial hypertrophy | FAERS: 1 | US FAERS | |
| 90 | Epilepsy | FAERS: 1 | US FAERS | |
| 91 | Eye Infection | FAERS: 1 | US FAERS | |
| 92 | Eye pain | FAERS: 1 | US FAERS | |
| 93 | Flatulence | FAERS: 1 | US FAERS | |
| 94 | Flushing | FAERS: 1 | US FAERS | |
| 95 | Formication | FAERS: 1 | US FAERS | |
| 96 | Frustration tolerance decreased | FAERS: 1 | US FAERS | |
| 97 | Hormone level abnormal | FAERS: 1 | US FAERS | |
| 98 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 99 | Hypogeusia | FAERS: 1 | US FAERS | |
| 100 | Hypohidrosis | FAERS: 1 | US FAERS | |
| 101 | Incorrect product storage | FAERS: 1 | US FAERS | |
| 102 | Medication residue present | FAERS: 1 | US FAERS | |
| 103 | Morbid thoughts | FAERS: 1 | US FAERS | |
| 104 | Muscle tightness | FAERS: 1 | US FAERS | |
| 105 | Musculoskeletal Pain | FAERS: 1 | US FAERS | |
| 106 | Musculoskeletal discomfort | FAERS: 1 | US FAERS | |
| 107 | Myopia | FAERS: 1 | US FAERS | |
| 108 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 109 | Nervousness | FAERS: 1 | US FAERS | |
| 110 | Oropharyngeal discomfort | FAERS: 1 | US FAERS | |
| 111 | Pancreatitis | FAERS: 1 | US FAERS | |
| 112 | Pelvic Pain | FAERS: 1 | US FAERS | |
| 113 | Photophobia | FAERS: 1 | US FAERS | |
| 114 | Premature Menopause | FAERS: 1 | US FAERS | |
| 115 | Product dose omission | FAERS: 1 | US FAERS | |
| 116 | Product lot number issue | FAERS: 1 | US FAERS | |
| 117 | Product use complaint | FAERS: 1 | US FAERS | |
| 118 | Pulmonary Embolism | FAERS: 1 | US FAERS | |
| 119 | Renal pain | FAERS: 1 | US FAERS | |
| 120 | Screaming | FAERS: 1 | US FAERS | |
| 121 | Seizure like phenomena | FAERS: 1 | US FAERS | |
| 122 | Sinus pain | FAERS: 1 | US FAERS | |
| 123 | Sinusitis | FAERS: 1 | US FAERS | |
| 124 | Skin Wrinkling | FAERS: 1 | US FAERS | |
| 125 | Skin reaction | FAERS: 1 | US FAERS | |
| 126 | Stomatitis | FAERS: 1 | US FAERS | |
| 127 | Stress | FAERS: 1 | US FAERS | |
| 128 | Swelling | FAERS: 1 | US FAERS | |
| 129 | Tension | FAERS: 1 | US FAERS | |
| 130 | Tinnitus | FAERS: 1 | US FAERS | |
| 131 | Tongue discomfort | FAERS: 1 | US FAERS | |
| 132 | Urinary tract infection | FAERS: 1 | US FAERS | |
| 133 | Vasculitis | FAERS: 1 | US FAERS | |
| 134 | Visual Impairment | FAERS: 1 | US FAERS | |
| 135 | Vulvovaginal pruritus | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.